article Open Access
Review on polypharmacy in HIV drugs
International journal of HIV and AIDS research. · 2019 · Vol. 1(1) · pp. 14–15
G. V. K. S. Abhinav✉(Jawaharlal Nehru Technological University, Kakinada)T Maneetha(Jawaharlal Nehru Technological University, Kakinada)G Nandini(Jawaharlal Nehru Technological University, Kakinada)V. Gayatri(Jawaharlal Nehru Technological University, Kakinada)Naga Subrahmanyam S(Jawaharlal Nehru Technological University, Kakinada)
Abstract
Polypharmacy means the use of a large number of medications. The use of all of them may not be in the patient's best interest. A common consequence is increasing adverse drug effect, some of which are due to drug interactions. Regular reviews are recommended to determine the appropriateness of use of all medications. Polypharmacy is defined as the simultaneous use of multiple drugs to treat a single ailment or condition, or the simultaneous use of multiple drugs by a single patient, for one or more conditions. HIV drugs may cause temporary side effects.
Pharmaceutical Economics and PolicyPharmaceutical studies and practicesAnalytical Methods in PharmaceuticalsPolypharmacyHuman immunodeficiency virus (HIV)MedicinePharmacologyIntensive care medicineVirology
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
55%
vs. same field & year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.